Feature|Videos|July 21, 2025
Video Interview With Chris Hagen, President of SCIEX
Author(s)SCIEX, Chris Hagen
Chris Hagen, President of SCIEX, shares his vision for the company and introduces the new ZenoTOF 8600 system, featuring electron activated dissociation (EAD) that provides more complete molecule identification and characterization and ZTScan for enhanced Q1 window selectivity.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5